FDA Warns on Statins

Thomas Burton & Ron Winslow
Wall Street Journal

The Food and Drug Administration raised safety concerns about the popular class of cholesterol-fighting drugs called statins, warning that patients taking the drugs may face a “small increased risk” of higher blood sugar levels and of being diagnosed with diabetes.

The federal safety agency said Tuesday it plans to add the diabetes-risk language to the “warnings and precautions” sections of labeling for the statin drugs. The drugs that will get the warning include top-selling brand names such as Lipitor, Lescol, Pravachol, Crestor, Mevacor, Altoprev, Livalo and Zocor.

Read More: FDA Warns on Statins

This entry was posted in Headlines, Health Related and tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply